Choosing an Analytical Partner in Early Drug Development

March 15, 2018
Feliza Mirasol

Feliza Mirasol is the science editor for BioPharm International.

BioPharm International, BioPharm International-03-15-2018, Volume 2018 eBook, Issue 1
Page Number: 27–29

Successful outsourcing relationships for early phase analytics in drug development are driven by partnership.

Criteria for choosing an analytical services partner during the early phase of drug development include scientific skills/knowledge and resource availability, and the type of relationship developed with an analytical service provider is typically defined by customer needs. To start with, the provider of early phase analytical studies should show that they have the necessary scientific skills and knowledge to support the program in question. Discussions between client and provider are also necessary to ensure that both parties are comfortable with what is required out of the relationship.

Read this article in BioPharm International'sOutsourcing Resources 2018 eBook.

View other articles in BioPharm International's Outsourcing Resources 2018 eBook.

Article Details

BioPharm International
eBook: Outsourcing Resources 2018
Vol. 31
March 2018
Pages: 27–29

Citation

When referring to this article, please cite it as F. Mirasol, " Choosing an Analytical Partner in Early Drug Development," BioPharm International Outsourcing Resources eBook (March 2018).